Item Type | Name |
Academic Article
|
Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease.
|
Academic Article
|
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.
|
Academic Article
|
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease.
|
Academic Article
|
The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies.
|
Academic Article
|
Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.
|
Academic Article
|
Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease.
|
Academic Article
|
Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.
|
Academic Article
|
Widespread distribution of reticulon-3 in various neurodegenerative diseases.
|
Academic Article
|
Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.
|
Academic Article
|
CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease.
|
Academic Article
|
Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.
|
Academic Article
|
Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.
|
Academic Article
|
Isotyping the human TOMM40 variable-length polymorphism by gene amplification and restriction digest.
|
Academic Article
|
Modification of amyloid-?1-42 fibril structure by methionine-35 oxidation.
|
Academic Article
|
A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules.
|
Academic Article
|
The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.
|
Academic Article
|
DNA damage in Alzheimer disease lymphocytes and its relation to premature centromere division.
|
Academic Article
|
Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance.
|
Academic Article
|
Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease.
|
Academic Article
|
A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks.
|
Academic Article
|
Antimicrobial peptide ?-defensin-1 expression is upregulated in Alzheimer's brain.
|
Academic Article
|
Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.
|
Academic Article
|
Fibrillar Amyloid-? Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3?Tg-AD Transgenic Mouse.
|
Academic Article
|
Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.
|
Academic Article
|
Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.
|
Academic Article
|
No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study.
|
Academic Article
|
Differences in structure and function between human and murine tau.
|
Academic Article
|
Neuropathology in Consecutive Forensic Consultation Cases with a History of Remote Traumatic Brain Injury.
|
Academic Article
|
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans.
|
Academic Article
|
Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies.
|
Academic Article
|
Distribution, levels, and activation of MEK1 in Alzheimer's disease.
|
Academic Article
|
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
|
Academic Article
|
Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
|
Academic Article
|
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease.
|
Academic Article
|
Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.
|
Academic Article
|
JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease.
|
Academic Article
|
Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?
|
Academic Article
|
Possible involvement of Wiskott-Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer's disease.
|
Academic Article
|
Increased p27, an essential component of cell cycle control, in Alzheimer's disease.
|
Academic Article
|
Neuroprotective properties of Bcl-w in Alzheimer disease.
|
Academic Article
|
Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease.
|
Academic Article
|
Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.
|
Academic Article
|
Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
|
Academic Article
|
Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions.
|
Academic Article
|
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations.
|
Academic Article
|
Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease.
|
Academic Article
|
Redox metals and oxidative abnormalities in human prion diseases.
|
Academic Article
|
Chitin-like polysaccharides in Alzheimer's disease brains.
|
Academic Article
|
Increased expression of p130 in Alzheimer disease.
|
Academic Article
|
Aberrant localization of importin alpha1 in hippocampal neurons in Alzheimer disease.
|
Academic Article
|
Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain.
|
Academic Article
|
Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathies.
|
Academic Article
|
Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis.
|
Academic Article
|
Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material.
|
Academic Article
|
Tau--an inhibitor of deacetylase HDAC6 function.
|
Academic Article
|
Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.
|
Academic Article
|
BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease.
|
Academic Article
|
Autophagocytosis of mitochondria is prominent in Alzheimer disease.
|
Concept
|
Aged, 80 and over
|
Academic Article
|
What is aging? What is its role in Alzheimer's disease? What can we do about it?
|
Academic Article
|
Alterations of the X Chromosome in Lymphocytes of Alzheimer's Disease Patients.
|
Academic Article
|
Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease.
|
Academic Article
|
Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential.
|
Academic Article
|
Serial reconstruction of beta-protein amyloid plaques: relationship to microvessels and size distribution.
|
Academic Article
|
Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease.
|
Academic Article
|
Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases.
|
Academic Article
|
Age-dependent pattern of intermediate filament protein expression in the human pineal gland.
|
Academic Article
|
Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
|
Academic Article
|
Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology.
|
Academic Article
|
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
|
Academic Article
|
Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease.
|
Academic Article
|
Influence of neuronal location on antigenic properties of neurofibrillary tangles.
|
Academic Article
|
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease.
|
Academic Article
|
Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease.
|
Academic Article
|
Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease.
|
Academic Article
|
The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease.
|
Academic Article
|
Antibodies to the neuronal cytoskeleton are elicited by Alzheimer paired helical filament fractions.
|
Academic Article
|
Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.
|
Academic Article
|
Alpha 1-trypsin immunoreactivity in Alzheimer disease.
|
Academic Article
|
Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease.
|
Academic Article
|
Widespread peroxynitrite-mediated damage in Alzheimer's disease.
|
Academic Article
|
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.
|
Academic Article
|
Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease.
|
Academic Article
|
Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease.
|
Academic Article
|
Characterization of the association of phospholipase C-delta with Alzheimer neurofibrillary tangles.
|
Academic Article
|
Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease.
|
Academic Article
|
Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases.
|
Academic Article
|
Abnormal accumulation of phospholipase C-delta in filamentous inclusions of human neurodegenerative diseases.
|
Academic Article
|
Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease.
|
Academic Article
|
Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Oxidative damage in Alzheimer's.
|
Academic Article
|
Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.
|
Academic Article
|
Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.
|
Academic Article
|
4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.
|
Academic Article
|
Levuglandin E2-protein adducts in human plasma and vasculature.
|
Academic Article
|
Abnormal localization of iron regulatory protein in Alzheimer's disease.
|
Academic Article
|
Cerebrovascular muscle atrophy is a feature of Alzheimer's disease.
|
Academic Article
|
Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine.
|
Academic Article
|
Striation is the characteristic neuritic abnormality in Alzheimer disease.
|
Academic Article
|
Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease.
|
Academic Article
|
CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains.
|
Academic Article
|
Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.
|
Academic Article
|
Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease.
|
Academic Article
|
In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.
|
Academic Article
|
Sequestration of iron by Lewy bodies in Parkinson's disease.
|
Academic Article
|
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
|
Academic Article
|
Protein disulfide isomerase in Alzheimer disease.
|
Academic Article
|
Evidence for a novel heme-binding protein, HasAh, in Alzheimer disease.
|
Academic Article
|
Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.
|
Academic Article
|
Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease.
|
Academic Article
|
Genetic evidence for oxidative stress in Alzheimer's disease.
|
Academic Article
|
Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?
|
Academic Article
|
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.
|
Academic Article
|
Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
|
Academic Article
|
Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc.
|
Academic Article
|
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.
|
Academic Article
|
Mitochondrial abnormalities in Alzheimer's disease.
|
Academic Article
|
Abortive apoptosis in Alzheimer's disease.
|
Academic Article
|
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.
|
Academic Article
|
Activation of MKK6, an upstream activator of p38, in Alzheimer's disease.
|
Academic Article
|
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
|
Academic Article
|
Neuronal binucleation in Alzheimer disease hippocampus.
|
Academic Article
|
Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
|
Academic Article
|
Phospho-Tau Protein Expression in the Cell Cycle of SH-SY5Y Neuroblastoma Cells: A Morphological Study.
|